Anti-Borrelia burgdorferi antibody profile in post-lyme disease syndrome

Clinical and Vaccine Immunology

Volumn 18, Issue 5, 2011, Pages 767-771

  Chandra, Abhishek ^a   Wormser, Gary P ^b   Marques, Adriana R ^c   Latov, Norman ^a   Alaedini, Armin ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM ANTIBODY; BORRELIA BURGDORFERI ANTIBODY; OUTER SURFACE PROTEIN A; PROTEIN P18; PROTEIN P25; PROTEIN P28; PROTEIN P30; PROTEIN P31; PROTEIN P34; PROTEIN P39; PROTEIN P41; PROTEIN P45; PROTEIN P58; PROTEIN P66; PROTEIN P93; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIGEN SPECIFICITY; ARTICLE; BORRELIA BURGDORFERI; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; LYME DISEASE; MAJOR CLINICAL STUDY; POST LYME DISEASE; PRIORITY JOURNAL; PROTEIN PURIFICATION; SEROLOGY; WESTERN BLOTTING;

ADULT; AGED; ANTIBODIES, BACTERIAL; AUTOMATION; BORRELIA BURGDORFERI; FEMALE; HUMANS; IMMUNOBLOTTING; LYME DISEASE; MALE; MIDDLE AGED;

EID: 79955713161     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00002-11     Document Type: Article

References (31)

1. Aguero-Rosenfeld, M. E., G. Wang, I. Schwartz, and G. P. Wormser. 2005. Diagnosis of lyme borreliosis. Clin. Microbiol. Rev. 18:484-509.
2. Akin, E., G. L. McHugh, R. A. Flavell, E. Fikrig, and A. C. Steere. 1999. The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect. Immun. 67:173-181.
3. Bockenstedt, L. K., J. Mao, E. Hodzic, S. W. Barthold, and D. Fish. 2002. Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment. J. Infect. Dis. 186:1430-1437.
4. Bratton, R. L., J. W. Whiteside, M. J. Hovan, R. L. Engle, and F. D. Edwards. 2008. Diagnosis and treatment of Lyme disease. Mayo Clin. Proc. 83:566-571.
5. CDC. 1995. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb. Mortal. Wkly. Rep. 44:590-591.
6. Chandra, A., et al. 2010. Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms. Brain Behav. Immun. 6:1018-1024.
7. Crowley, H., and B. T. Huber. 2003. Host-adapted Borrelia burgdorferi in mice expresses OspA during inflammation. Infect. Immun. 71:4003-4010.
8. Das, S., et al. 1996. Characterization of a 30-kDa Borrelia burgdorferi substrate-binding protein homologue. Res. Microbiol. 147:739-751.
9. Dressler, F., J. A. Whalen, B. N. Reinhardt, and A. C. Steere. 1993. Western blotting in the serodiagnosis of Lyme disease. J. Infect. Dis. 167:392-400.
10. Fallon, B. A., et al. 2008. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 70:992-1003. (Pubitemid 351451323)
11. Feder, H. M., Jr., et al. 2007. A critical appraisal of "chronic Lyme disease." N. Engl. J. Med. 357:1422-1430.
12. Halperin, J. J. 2008. Nervous system Lyme disease. Infect. Dis. Clin. North Am. 22:261-274.
13. Hodzic, E., S. Feng, K. Holden, K. J. Freet, and S. W. Barthold. 2008. Persistence of Borrelia burgdorferi following antibiotic treatment in mice. Antimicrob. Agents Chemother. 52:1728-1736.
14. Kalish, R. A., J. M. Leong, and A. C. Steere. 1993. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect. Immun. 61:2774-2779.
15. Kalish, R. A., J. M. Leong, and A. C. Steere. 1995. Early and late antibody responses to full-length and truncated constructs of outer surface protein A of Borrelia burgdorferi in Lyme disease. Infect. Immun. 63:2228-2235.
16. Klempner, M. S., et al. 2001. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N. Engl. J. Med. 345:85-92.
17. Krupp, L. B., et al. 2003. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology 60:1923-1930. (Pubitemid 36736007)
18. Lin, T., J. H. Oliver, Jr., L. Gao, T. M. Kollars, Jr., and K. L. Clark. 2001. Genetic heterogeneity of Borrelia burgdorferi sensu lato in the southern United States based on restriction fragment length polymorphism and sequence analysis. J. Clin. Microbiol. 39:2500-2507.
19. Ma, B., B. Christen, D. Leung, and C. Vigo-Pelfrey. 1992. Serodiagnosis of Lyme borreliosis by Western immunoblot: reactivity of various significant antibodies against Borrelia burgdorferi. J. Clin. Microbiol. 30:370-376.
20. Marques, A. 2008. Chronic Lyme disease: a review. Infect. Dis. Clin. North Am. 22:341-360.
21. Marques, A. R. 2010. Lyme disease: a review. Curr. Allergy Asthma Rep. 10:13-20.
22. Nowalk, A. J., R. D. Gilmore, Jr., and J. A. Carroll. 2006. Serologic proteome analysis of Borrelia burgdorferi membrane-associated proteins. Infect. Immun. 74:3864-3873.
23. Stanek, G., and F. Strle. 2003. Lyme borreliosis. Lancet 362:1639-1647. (Pubitemid 37443533)
24. Steere, A. C. 2001. Lyme disease. N. Engl. J. Med. 345:115-125.
25. Steere, A. C., J. Coburn, and L. Glickstein. 2004. The emergence of Lyme disease. J. Clin. Invest. 113:1093-1101.
26. Straubinger, R. K. 2000. PCR-based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-day postinfection period. J. Clin. Microbiol. 38:2191-2199.
27. Straubinger, R. K., B. A. Summers, Y. F. Chang, and M. J. Appel. 1997. Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. J. Clin. Microbiol. 35:111-116.
28. Wormser, G. P., et al. 2008. Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease. J. Infect. Dis. 198:1358-1364.
29. Wormser, G. P., et al. 2006. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 43:1089-1134.
30. Wormser, G. P., et al. 2008. Effect of Borrelia burgdorferi genotype on the sensitivity of C6 and 2-tier testing in North American patients with culture-confirmed Lyme disease. Clin. Infect. Dis. 47:910-914.
31. Wormser, G. P., et al. 1999. Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease. J. Infect. Dis. 180:720-725.